Thorne Healthtech, Inc.

Thorne Healthtech, Inc. (THRN) priced its initial public offering on Sep 23, 2021 at $10.00 per share, within its $10.00–$11.00 range, raising $70M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $525.1M. BofA Securities was lead-left underwriter, joined by TD Cowen, Evercore ISI and RBC Capital Markets. Wilson Sonsini advised the company and Latham & Watkins advised the underwriters.

Thorne Healthtech, Inc. is a science-driven wellness company offering personalized approaches to health and well-being. It uses testing, education and proactive measures to help customers avoid chronic health conditions and increase their health span.

Status

IPO

Ticker

THRN

Exchange

Nasdaq Global Select

Priced

Sep 23, 2021

IPO price

$10.00

Price range

$10.00–$11.00

Raised

$70M

Market cap at IPO price

$525.1M

First filed

Jul 16, 2021

Underwriters

BofA Securities, TD Cowen, Evercore ISI and RBC Capital Markets

Company counsel

Wilson Sonsini

Underwriters' counsel

Latham & Watkins

Sector

Biotech & pharma

Country / state

SC

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.